| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 214,320 | 212,549 | 206,434 | 193,954 | | Cost of Revenue | 127,468 | 128,871 | 126,974 | 123,236 | | | Gross Profit | 86,852 | 83,678 | 79,460 | 70,718 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 23,442 | 22,773 | 24,893 | 20,934 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 23,428 | 22,635 | 22,064 | 20,447 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 39,982 | 38,270 | 32,503 | 29,337 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (139) | 139 | 116 | | Earnings Before Interest And Taxes | 40,298 | 38,463 | 32,979 | 29,711 | | Interest Expense | 7,651 | 7,741 | 7,613 | 8,367 | | Income Before Tax | 32,647 | 30,722 | 25,366 | 21,344 | | Income Tax Expense | 12,014 | 12,462 | 10,252 | 8,329 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 20,633 | 18,260 | 15,114 | 13,015 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 20,633 | 18,260 | 15,114 | 13,015 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $20,633 | $18,260 | $15,114 | $13,015 |
|
0.50% Nasdaq 0.00%
Income Statement
